本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc Series A P

6.93
+0.18352.72%
盘后6.930.00000.00%16:42 EDT
成交量:5,056.00
成交额:3.53万
市值:2,376.18万
市盈率:-3.16
高:7.10
开:6.77
低:6.77
收:6.75
52周最高:9.85
52周最低:4.72
股本:342.71万
流通股本:342.71万
量比:0.75
换手率:0.15%
股息:- -
股息率:- -
每股收益(TTM):-2.1959
每股收益(LYR):-2.6890
净资产收益率:-746.25%
总资产收益率:-32.37%
市净率:1.07
市盈率(LYR):-2.58

数据加载中...

2020/05/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/19

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/11

重要事件披露

Current report, items 2.02 and 9.01
2020/05/11

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/04/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/23

重要事件披露

8-K - Current report
2020/03/16

重要事件披露

Current report, items 2.02 and 9.01
2020/03/16

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/27

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/31

重要事件披露

Current report, item 5.02
2019/11/26

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/26

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/22

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]